Company intelligence / Profile preview

Rivermount VC Fund

San Francisco Bay Area / Silicon Valley, California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

Rivermount VC Fund is an active venture capital firm based in Silicon Valley/Delaware that invests primarily in early-stage high-tech and healthcare/life science startups. Its portfolio includes companies developing novel medical devices, diagnostics, therapeutics for neurological disorders like epilepsy (e.g., Neurava), oncology drugs (e.g., Trio Pharmaceuticals), and other innovative health technologies. The fund has participated in recent seed rounds such as Neurava’s $2.26M raise for smart wearable seizure detection devices[2][3].

Therapeutic areas: OncologyNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyDeviceBiologic
Industry: Investors

Partnerships

UCB Pharma’s strategic investment into Neurava

Beyond the preview

Go deeper on Rivermount VC Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rivermount VC Fund.

Explore the full profile